IGF-1 DES 2mg

IGF-1 DES 2mg
£90.00

(NOT FOR HUMAN CONSUMPTION RESEARCH USE ONLY) 

IGF-1 DES 2mg

(Insulin-like Growth Factor-1 DES 1-3) is a highly potent, truncated version of the IGF-1 hormone. It is approximately 10 times more potent than standard IGF-1 because it lacks three specific amino acids at its N-terminus, which prevents it from binding to IGF-binding proteins (IGFBPs) that would normally deactivate it. 

 

Key Characteristics and Function

  • Site-Specific Growth: Due to a very short half-life of 20–30 minutes, it is primarily effective at the specific site of injection.
  • Hyperplasia Stimulation: Unlike regular IGF-1, which mostly increases the size of existing muscle cells (hypertrophy), IGF-1 DES is known to activate dormant satellite cells to create newmuscle fibers (hyperplasia).
  • Lactic Acid Affinity: It can bind to receptors even in the presence of lactic acid, which typically blocks other growth factors during intense exercise, making it uniquely effective when used intra-workout. 

 

Comparison: IGF-1 DES vs. IGF-1 LR3

Feature          IGF-1 DES                                      IGF-1 LR320

Half-Life.       20–30 minutes                               20–30hours 

Mechanism.   Targeted, site-specific                   Systemic, full-body

Potency         10x local receptor affinity             High systemic bioavailability

Best Use     Lagging muscle groups/injury        General mass gain

 

–Half-Life hoursTargeted, site-, full-body10x local receptor affinityHigh systemic bioavailabilityLagging muscle groups/injuryGeneral mass gain

 

 

Potential Research Benefits

  • Muscle Repair: Accelerates recovery of damaged muscle, tendons, and ligaments by enhancing protein synthesis.
  • Gut Health: Studies in animal models show it may have anabolic effects on gut tissues, suggesting potential future research for inflammatory bowel diseases.
  • Immune Support: Preliminary research indicates it may boost certain immune functions by encouraging the differentiation of pathogen-killing cells. 

 

Safety and Regulatory Status

  • FDA Status: IGF-1 DES is not approved for human consumption and is sold strictly for laboratory research purposes.
  • Doping Status: It is prohibited by the World Anti-Doping Agency (WADA).
  • Risks: While systemic risks like hypoglycemia are lower than with LR3 due to its fast clearance, localized side effects include injection site irritation and inflammation. There is a theoretical risk of accelerating the growth of undiagnosed tumors.